Status:
COMPLETED
Functional Medical Imaging Quantization in Prostate Cancer
Lead Sponsor:
University Hospital, Brest
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
Prostate cancer is the most common cancer in men over 50 years old and the third leading cause of cancer death. Because of the variety of prostate cancers, different treatments exist. Several criteri...
Eligibility Criteria
Inclusion
- Patients with prostate cancer histologically proven included in Brest University Hospital between 01/07/2012 and 01/10/2015 and underwent F-choline PET/CT and pelvic MRI Patient consent
Exclusion
- No lesion on dynamic acquisition on PET/CT and/or on pelvic MRI
Key Trial Info
Start Date :
October 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2017
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT03376360
Start Date
October 1 2015
End Date
May 1 2017
Last Update
August 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609